Jove
Visualize
Contact Us

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.

Vaccine·2022
Same author

FTIR Spectroscopy Detects Intermolecular β-Sheet Formation Above the High Temperature T<sub>m</sub> for Two Monoclonal Antibodies.

The protein journal·2020
Same author

High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.

Pharmaceutical research·2018
Same author

Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.

PDA journal of pharmaceutical science and technology·2018
Same author

Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies.

Journal of pharmaceutical sciences·2016
Same author

Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.

Vaccine·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 28, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.0K

Microfluidic and Turbulent Mixing for mRNA LNP Vaccines.

Patrick L Ahl1

  • 1PLA Formulation Consulting LLC, Princeton, NJ 08540, USA.

Pharmaceutics
|September 27, 2025
PubMed
Summary

This review explores mixing processes for mRNA lipid nanoparticles (LNPs) used in vaccine development. Both microfluidic and turbulent mixing methods can create effective mRNA LNPs, but turbulent mixing is better for large-scale production.

Keywords:
LNPmRNAmicrofluidicnanoparticleturbulentvaccines

More Related Videos

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

13.8K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

5.9K

Related Experiment Videos

Last Updated: May 28, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.0K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

13.8K
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
08:10

Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries

Published on: August 23, 2024

5.9K

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Nanotechnology and Materials Science
  • Immunology and Vaccine Development

Background:

  • Lipid nanocarriers are crucial for delivering mRNA antigens to immune cells, enabling rapid vaccine development.
  • Optimizing the mixing process is essential for the successful self-assembly of mRNA lipid nanoparticles (LNPs).

Purpose of the Study:

  • To review the fundamentals of microfluidic and turbulent fluid mixing for mRNA LNP formulation.
  • To discuss the mRNA LNP self-assembly process via flash nanoprecipitation.
  • To summarize current LNP mixing technologies and their suitability for different scales.

Main Methods:

  • Review of microfluidic and turbulent fluid mixing principles.
  • Discussion of the flash nanoprecipitation/self-assembly process for mRNA LNPs.
  • Analysis of experimental studies on mRNA LNP mixing.
  • Summary of commercially available LNP mixing technologies.

Main Results:

  • Both chaotic advection (microfluidic) and turbulent flow mixing devices can formulate similar mRNA LNPs.
  • No single mixing process is universally optimal for all nanoparticle and mRNA LNP formulations.
  • Microfluidic devices have limited fluid output, making them less practical for high-throughput applications.

Conclusions:

  • Turbulent mixing devices are more suitable for clinical-scale mRNA LNP production due to higher fluid output.
  • The choice of mixing technology depends on the specific application and required production scale.
  • Further optimization of mixing parameters is key for efficient mRNA LNP vaccine development.